Browse by Nurse Practitioner Items
Nurse practitioner PBS prescribing
MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS
From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners). Information for nurse practitioners to become authorised PBS prescribers is available from Services Australia.
The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.
PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.
The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.
Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:
- Continuing therapy only model
Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)
- Shared care model
Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.
Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.
Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.
Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms. For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms. Nurse practitioner PBS prescriptions may include repeats.
Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.
Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from Services Australia for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)
State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.
- Legend
- MPMedical Practitioner
- NPNurse Practitioner
Prescriber code | Item code | Name, manner of administration and form & strength | Max qty packs |
Max qty units |
No. of repeats |
---|---|---|---|---|---|
MPNP | 11123K | SACUBITRIL + VALSARTANsacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 | 1 | 56 | 5 |
MPNP | 13570F | SACUBITRIL + VALSARTANsacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 | 2 | 112 | 5 |
MPNP | 11131W | SACUBITRIL + VALSARTANsacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 | 1 | 56 | 5 |
MPNP | 13511D | SACUBITRIL + VALSARTANsacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 | 2 | 112 | 5 |
MPNP | 11122J | SACUBITRIL + VALSARTANsacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 | 1 | 56 | 5 |
MPNP | 13445P | SACUBITRIL + VALSARTANsacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 | 2 | 112 | 5 |
MPNP | 11656L | SAFINAMIDEsafinamide 50 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 11666B | SAFINAMIDEsafinamide 100 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 12108G | SALBUTAMOLsalbutamol 100 microgram/actuation inhalation, 200 actuations | 1 | 1 | 0 |
MPNP | 12109H | SALBUTAMOLsalbutamol 100 microgram/actuation inhalation, 200 actuations | 2 | 2 | 5 |
MPNP | 2000G | SALBUTAMOLsalbutamol 2.5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules | 2 | 2 | 5 |
MPNP | 3496B | SALBUTAMOLsalbutamol 2.5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules | 1 | 1 | 0 |
MPNP | 2001H | SALBUTAMOLsalbutamol 5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules | 2 | 2 | 5 |
MPNP | 3497C | SALBUTAMOLsalbutamol 5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules | 1 | 1 | 0 |
MPNP | 8354Q | SALBUTAMOLsalbutamol 100 microgram/actuation breath activated inhalation, 200 actuations | 2 | 2 | 5 |
MPNP | 1103C | SALBUTAMOLsalbutamol 2 mg/5 mL oral liquid, 150 mL | 2 | 2 | 5 |
MPNP | 11125M | SALBUTAMOLsalbutamol 2.5 mg/2.5 mL inhalation solution, 20 x 2.5 mL ampoules | 1 | 1 | 0 |
MPNP | 13821K | SALBUTAMOLsalbutamol 2.5 mg/2.5 mL inhalation solution, 20 x 2.5 mL ampoules | 3 | 3 | 5 |
MPNP | 13828T | SALBUTAMOLsalbutamol 2.5 mg/2.5 mL inhalation solution, 20 x 2.5 mL ampoules | 1 | 1 | 0 |
MPNP | 11130T | SALBUTAMOLsalbutamol 2.5 mg/2.5 mL inhalation solution, 20 x 2.5 mL ampoules | 3 | 3 | 5 |
MPNP | 11088N | SALBUTAMOLsalbutamol 5 mg/2.5 mL inhalation solution, 20 x 2.5 mL ampoules | 1 | 1 | 0 |
MPNP | 11095Y | SALBUTAMOLsalbutamol 5 mg/2.5 mL inhalation solution, 20 x 2.5 mL ampoules | 3 | 3 | 5 |
MPNP | 8141L | SALMETEROLsalmeterol 50 microgram/actuation powder for inhalation, 60 actuations | 1 | 1 | 5 |
MPNP | 11970B | SAPROPTERINsapropterin dihydrochloride 500 mg powder for oral liquid, 30 sachets | 1 | 30 | 5 |
MPNP | 11983Q | SAPROPTERINsapropterin dihydrochloride 500 mg powder for oral liquid, 30 sachets | 1 | 30 | 5 |
MPNP | 10087X | SAPROPTERINsapropterin dihydrochloride 100 mg soluble tablet, 30 | 6 | 180 | 5 |
MPNP | 11691H | SAPROPTERINsapropterin dihydrochloride 100 mg soluble tablet, 30 | 6 | 180 | 5 |
MPNP | 12569M | SAPROPTERINsapropterin dihydrochloride 100 mg soluble tablet, 30 | 1 | 30 | 5 |
MPNP | 13923T | SAXAGLIPTINsaxagliptin 5 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 8983T | SAXAGLIPTINsaxagliptin 5 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 10128C | SAXAGLIPTINsaxagliptin 2.5 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13895H | SAXAGLIPTINsaxagliptin 2.5 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 11305B | SAXAGLIPTIN + DAPAGLIFLOZINsaxagliptin 5 mg + dapagliflozin 10 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13855F | SAXAGLIPTIN + DAPAGLIFLOZINsaxagliptin 5 mg + dapagliflozin 10 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 10055F | SAXAGLIPTIN + METFORMINsaxagliptin 5 mg + metformin hydrochloride 500 mg modified release tablet, 28 | 1 | 28 | 5 |
MPNP | 14030K | SAXAGLIPTIN + METFORMINsaxagliptin 5 mg + metformin hydrochloride 500 mg modified release tablet, 28 | 2 | 56 | 5 |
MPNP | 10051B | SAXAGLIPTIN + METFORMINsaxagliptin 5 mg + metformin hydrochloride 1 g modified release tablet, 28 | 1 | 28 | 5 |
MPNP | 13876H | SAXAGLIPTIN + METFORMINsaxagliptin 5 mg + metformin hydrochloride 1 g modified release tablet, 28 | 2 | 56 | 5 |
MPNP | 10048W | SAXAGLIPTIN + METFORMINsaxagliptin 2.5 mg + metformin hydrochloride 1 g modified release tablet, 56 | 1 | 56 | 5 |
MPNP | 13880M | SAXAGLIPTIN + METFORMINsaxagliptin 2.5 mg + metformin hydrochloride 1 g modified release tablet, 56 | 2 | 112 | 5 |
MPNP | 1973W | SELEGILINEselegiline hydrochloride 5 mg tablet, 100 | 1 | 100 | 5 |
MPNP | 12080T | SEMAGLUTIDEsemaglutide 1.34 mg/mL injection, 1 x 1.5 mL pen device | 1 | 1 | 5 |
MPNP | 12075M | SEMAGLUTIDEsemaglutide 1.34 mg/mL injection, 1 x 3 mL pen device | 1 | 1 | 5 |
MPNP | 2237R | SERTRALINEsertraline 100 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 8837D | SERTRALINEsertraline 100 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 2236Q | SERTRALINEsertraline 50 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 8836C | SERTRALINEsertraline 50 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 11856B | SEVELAMERsevelamer carbonate 800 mg tablet, 180 | 1 | 180 | 5 |
MPNP | 14027G | SEVELAMERsevelamer carbonate 800 mg tablet, 180 | 2 | 360 | 5 |
MPNP | 13934J | SEVELAMERsevelamer hydrochloride 800 mg tablet, 180 | 2 | 360 | 5 |
MPNP | 2142R | SEVELAMERsevelamer hydrochloride 800 mg tablet, 180 | 1 | 180 | 5 |
MPNP | 9479X | SILVER SULFADIAZINEsilver sulfadiazine 1% cream, 50 g | 1 | 1 | 0 |
MPNP | 13528B | SIMVASTATINsimvastatin 10 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 2011W | SIMVASTATINsimvastatin 10 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13373W | SIMVASTATINsimvastatin 20 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 2012X | SIMVASTATINsimvastatin 20 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13471B | SIMVASTATINsimvastatin 40 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 8173E | SIMVASTATINsimvastatin 40 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13559P | SIMVASTATINsimvastatin 5 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 2013Y | SIMVASTATINsimvastatin 5 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13498K | SIMVASTATINsimvastatin 80 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 8313M | SIMVASTATINsimvastatin 80 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13871C | SITAGLIPTINsitagliptin 100 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 9182G | SITAGLIPTINsitagliptin 100 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 14021Y | SITAGLIPTINsitagliptin 25 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 9180E | SITAGLIPTINsitagliptin 25 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 14058X | SITAGLIPTINsitagliptin 50 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 9181F | SITAGLIPTINsitagliptin 50 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 14064F | SITAGLIPTIN + METFORMINsitagliptin 50 mg + metformin hydrochloride 850 mg tablet, 56 | 2 | 112 | 5 |
MPNP | 9450J | SITAGLIPTIN + METFORMINsitagliptin 50 mg + metformin hydrochloride 850 mg tablet, 56 | 1 | 56 | 5 |
MPNP | 14035Q | SITAGLIPTIN + METFORMINsitagliptin 50 mg + metformin hydrochloride 1 g tablet, 56 | 2 | 112 | 5 |
MPNP | 9451K | SITAGLIPTIN + METFORMINsitagliptin 50 mg + metformin hydrochloride 1 g tablet, 56 | 1 | 56 | 5 |
MPNP | 13994M | SITAGLIPTIN + METFORMINsitagliptin 50 mg + metformin hydrochloride 500 mg tablet, 56 | 2 | 112 | 5 |
MPNP | 9449H | SITAGLIPTIN + METFORMINsitagliptin 50 mg + metformin hydrochloride 500 mg tablet, 56 | 1 | 56 | 5 |
MPNP | 10089B | SITAGLIPTIN + METFORMINsitagliptin 100 mg + metformin hydrochloride 1 g tablet: modified release, 28 | 1 | 28 | 5 |
MPNP | 14031L | SITAGLIPTIN + METFORMINsitagliptin 100 mg + metformin hydrochloride 1 g tablet: modified release, 28 | 2 | 56 | 5 |
MPNP | 10090C | SITAGLIPTIN + METFORMINsitagliptin 50 mg + metformin hydrochloride 1 g modified release tablet, 56 | 1 | 56 | 5 |
MPNP | 13990H | SITAGLIPTIN + METFORMINsitagliptin 50 mg + metformin hydrochloride 1 g modified release tablet, 56 | 2 | 112 | 5 |
MPNP | 3196F | SODIUM CHLORIDE + POTASSIUM CHLORIDE + GLUCOSE + CITRIC ACIDsodium chloride 470 mg + potassium chloride 300 mg (potassium 4 mmol) + glucose monohydrate 3.56 g + sodium acid citrate 530 mg powder for oral liquid, 10 x 4.9 g sachets | 1 | 1 | 0 |
MPNP | 11865L | SODIUM PHENYLBUTYRATEsodium phenylbutyrate 483 mg/g granules, 174 g | 3 | 3 | 5 |
MPNP | 11144M | SOFOSBUVIR + VELPATASVIRsofosbuvir 400 mg + velpatasvir 100 mg tablet, 28 | 1 | 28 | 2 |
MPNP | 11145N | SOFOSBUVIR + VELPATASVIRsofosbuvir 400 mg + velpatasvir 100 mg tablet, 28 | 1 | 28 | 2 |
MPNP | 11147Q | SOFOSBUVIR + VELPATASVIRsofosbuvir 400 mg + velpatasvir 100 mg tablet, 28 | 1 | 28 | 2 |
MPNP | 11658N | SOFOSBUVIR + VELPATASVIR + VOXILAPREVIRsofosbuvir 400 mg + velpatasvir 100 mg + voxilaprevir 100 mg tablet, 28 | 1 | 28 | 2 |
MPNP | 11659P | SOFOSBUVIR + VELPATASVIR + VOXILAPREVIRsofosbuvir 400 mg + velpatasvir 100 mg + voxilaprevir 100 mg tablet, 28 | 1 | 28 | 2 |
MPNP | 11665Y | SOFOSBUVIR + VELPATASVIR + VOXILAPREVIRsofosbuvir 400 mg + velpatasvir 100 mg + voxilaprevir 100 mg tablet, 28 | 1 | 28 | 2 |
MPNP | 2043M | SOTALOLsotalol hydrochloride 160 mg tablet, 60 | 1 | 60 | 5 |
MPNP | 8398B | SOTALOLsotalol hydrochloride 80 mg tablet, 60 | 1 | 60 | 5 |
MPNP | 9448G | SOY LECITHIN + TOCOPHEROL + VITAMIN Asoy lecithin 1% + tocopherol 0.002% + vitamin A palmitate 0.025% spray, 100 actuations | 2 | 2 | 5 |
MPNP | 8577K | SOY PROTEIN AND FAT FORMULA WITH VITAMINS AND MINERALS CARBOHYDRATE FREEsoy protein and fat formula with vitamins and minerals carbohydrate free oral liquid, 384 mL can | 120 | 120 | 5 |
MPNP | 2340E | SPIRONOLACTONEspironolactone 100 mg tablet, 100 | 1 | 100 | 5 |
MPNP | 14042C | SPIRONOLACTONEspironolactone 100 mg tablet, 100 | 2 | 200 | 5 |
MPNP | 2339D | SPIRONOLACTONEspironolactone 25 mg tablet, 100 | 1 | 100 | 5 |
MPNP | 13503Q | SPIRONOLACTONEspironolactone 25 mg tablet, 100 | 2 | 200 | 5 |
MPNP | 10250L | SUCROFERRIC OXYHYDROXIDEsucroferric oxyhydroxide 2.5 g (iron 500 mg) chewable tablet, 90 | 1 | 90 | 5 |
MPNP | 13985C | SUCROFERRIC OXYHYDROXIDEsucroferric oxyhydroxide 2.5 g (iron 500 mg) chewable tablet, 90 | 2 | 180 | 5 |
MPNP | 13557M | SULFASALAZINEsulfasalazine 500 mg tablet, 100 | 4 | 400 | 5 |
MPNP | 2093E | SULFASALAZINEsulfasalazine 500 mg tablet, 100 | 2 | 200 | 5 |
MPNP | 13433B | SULFASALAZINEsulfasalazine 500 mg enteric tablet, 100 | 4 | 400 | 5 |
MPNP | 2096H | SULFASALAZINEsulfasalazine 500 mg enteric tablet, 100 | 2 | 200 | 5 |
MPNP | 14016Q | SULTHIAMEsulthiame 200 mg tablet, 200 | 2 | 400 | 2 |
MPNP | 2100M | SULTHIAMEsulthiame 200 mg tablet, 200 | 1 | 200 | 2 |
MPNP | 13916K | SULTHIAMEsulthiame 50 mg tablet, 200 | 2 | 400 | 2 |
MPNP | 2099L | SULTHIAMEsulthiame 50 mg tablet, 200 | 1 | 200 | 2 |
MPNP | 8144P | SUMATRIPTANsumatriptan 50 mg tablet, 2 | 2 | 4 | 5 |
MPNP | 1849H | SUMATRIPTANsumatriptan 50 mg tablet, 4 | 1 | 4 | 5 |
MPNP | 10694W | SUMATRIPTANSUMATRIPTAN Tablet 50 mg (base) (fast disintegrating), 4 | 1 | 4 | 5 |
MPNP | 8341B | SUMATRIPTANsumatriptan 20 mg/actuation nasal spray, 2 x 1 actuation | 1 | 2 | 5 |